Bioprocessing - Upstream & Downstream

Making the right decisions in monoclonal antibody production

The Medicine Maker and NIBRT present the Biopharma Trends Leaders’ Report 2022.

Cell and gene therapy manufacturers need to make better plasmid design decisions with commercialization in mind.

Single-use technology continues to evolve; single-use bags are now a robust alternative to using bottles in freeze and thaw.

With mRNA offering more straightforward development and manufacturing processes, are the days of traditional vaccine modalities numbered?

What happened in May in the biopharma industry? Here’s our roundup of the biggest headlines.

COVID-19 has taught us that unexpected events can cause significant supply chain disruption, so pharma must be prepared.

How can pharma help save the environment? We need to use green chemistry, reduce cleanroom sizes, and use less energy.

Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.

Efficient and reliable scale up is a key component of mAb production.